Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
about
Novel drugs that target the metabolic reprogramming in renal cell cancerFrontiers in clinical and molecular diagnostics and staging of metastatic clear cell renal cell carcinomaGenetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNAFructose-1,6-bisphosphatase opposes renal carcinoma progressionGenome-wide association study reveals a polymorphism in the podocyte receptor RANK for the decline of renal function in coronary patients.Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lungRecurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.Non-diethylstilbestrol exposed vaginal clear cell adenocarcinoma has a common molecular profile with ovarian clear cell adenocarcinoma: A case reportStratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisSQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer.Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesAlpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.Targeting FBPase is an emerging novel approach for cancer therapy.
P2860
Q26740187-C6B08CDF-4F0F-4525-98C3-D5CEFCC4542FQ26863402-0D655CE6-9CA8-4FE3-BCA5-7920468A35EAQ33709786-D028CF92-109E-4CDF-9217-854B84C3B5C4Q34173576-79EF013D-91E8-450C-8DC8-8172FD45E0D7Q34640574-7D7BB428-4E05-4DBC-9299-91687D97D092Q34795438-628C7E65-8023-4AA5-8F6E-F34D20EE50E3Q35247152-F83A17DA-D833-4A70-88BB-8A897817D5C8Q35692212-A4C6AD6F-392E-43C8-A01C-DF0C41E7E680Q36367103-A6DAC6AA-755D-4EC7-BDBB-486E42B6F7C2Q37542249-E4DA1B9B-AA4A-4AC8-A105-D843F450FE53Q38668393-4E250DBD-C140-4FF8-B575-9F5E08F9B7D1Q38939134-1D446A54-7A21-431F-9640-F256D533B1F0Q41698566-5F3377C8-9B16-4133-AC67-9CB63B6D4EC6Q52647812-C51142CC-6B97-41AC-B10B-D22CF7752AA3
P2860
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Genomic copy number alteration ...... nisms of VHL gene inactivation
@ast
Genomic copy number alteration ...... nisms of VHL gene inactivation
@en
Genomic copy number alteration ...... nisms of VHL gene inactivation
@nl
type
label
Genomic copy number alteration ...... nisms of VHL gene inactivation
@ast
Genomic copy number alteration ...... nisms of VHL gene inactivation
@en
Genomic copy number alteration ...... nisms of VHL gene inactivation
@nl
prefLabel
Genomic copy number alteration ...... nisms of VHL gene inactivation
@ast
Genomic copy number alteration ...... nisms of VHL gene inactivation
@en
Genomic copy number alteration ...... nisms of VHL gene inactivation
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Genomic copy number alteration ...... nisms of VHL gene inactivation
@en
P2093
F M Waldman
M L Nickerson
M Navratilova
P2860
P2888
P3181
P356
10.1038/ONCSIS.2012.14
P407
P50
P577
2012-06-25T00:00:00Z
P5875
P6179
1008118735